Clinical experience with oral topotecan in relapsed small cell lung cancer patients following irinotecan-platinum chemotherapy

Publisher： Jaypee Infomedia

E-ISSN： 2278-0262|50|2|110-111

ISSN： 2277-8969

Source： Jourrnal of Postgraduate Medicine Education & Research, Vol.50, Iss.2, 2016-04, pp. : 110-111

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Phase II study of biweekly administration of docetaxel and irinotecan in patients with refractory or relapsed advanced non-small cell lung cancer

By Hirose Takashi   Shirai Takao   Ishida Hiroo   Ando Kohichi   Sugiyama Tomohide   Kusumoto Sojiro   Hosaka Takamichi   Nakashima Masanao   Ohmori Tohru   Adachi Mitsuru  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 2, 2007-07 ,pp. : 267-274

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and Safety of Platinum Combination Chemotherapy Re-Challenge for Relapsed Patients with Non-Small-Cell Lung Cancer after Postoperative Adjuvant Chemotherapy of Cisplatin plus Vinorelbine

By  

Chemotherapy, Vol. 59, Iss. 4, 2014-01 ,pp. : 307-313

Karger

Access to resources Recommend Favorite

Phase II study of irinotecan and amrubicin in patients with relapsed non-small cell lung cancer: Okayama Lung Cancer Study Group Trial 0402

By Nogami Naoyuki   Hotta Katsuyuki   Segawa Yoshihiko   Takigawa Nagio   Hosokawa Shinobu   Oze Isao   Fujii Masanori   Ichihara Eiki   Shibayama Takuo   Tada Atsuhiko   Hamada Noboru   Uno Masatoshi   Tamaoki Akihiko   Kuyama Shoichi   Ikeda Genyo   Osawa Masahiro   Takata Saburo   Tabata Masahiro   Tanimoto Mitsune   Kiura Katsuyuki  

Acta Oncologica, Vol. 51, Iss. 6, 2012-07 ,pp. : 768-773

Informa Healthcare

Access to resources Recommend Favorite

Combination Chemotherapy with Irinotecan and Ifosfamide as Second-Line Treatment of Refractory or Sensitive Relapsed Small Cell Lung Cancer: A Phase II Study

By  

Chemotherapy, Vol. 49, Iss. 4, 2003-07 ,pp. : 200-205

Karger

Access to resources Recommend Favorite

Activity of weekly irinotecan (CPT-11) in patients with advanced non-small cell lung cancer pretreated with platinum and taxanes

By Sánchez Rosa   Esteban Emilio   Palacio Isabel   Fernández Yolanda   Muñiz Isabel   Vieitez Jose M.   Fra Joaquin   Blay Pilar   Villanueva Noemí   Uña Esther   Mareque Beatriz   Estrada Enrique   Buesa Jose M.   Lacave Angel J.  

Investigational New Drugs, Vol. 21, Iss. 4, 2003-11 ,pp. : 459-463

Springer Publishing Company

Access to resources Recommend Favorite